Following resuscitation with naloxone, clinicians commonly recommend an observation period to monitor for rebound apnea and other symptoms. Patient refusal of this recommendation is common, although rarely discussed in the literature.
Patients perception of poor sleep differ from EEG-reported results.
The longer patients continue with buprenorphine treatment, the lower their risk of adverse outcomes.
While claims about the benefits of Vivitrol were clearly presented in the ad, serious risks, such as vulnerability to opioid overdose, were not communicated.
Traditionally, suicide and overdose prevention in opioid use disorder involve stratifying risk based on certain demographic and clinical factors.
Overall, of 333 adult patients, 15.9% of patients reported opioid misuse, 17.1% were positive for PTSD, and 52.6% were positive for depression.
Researchers sought to describe the practice patterns of NPs and PAs, understand the barriers these providers face in providing buprenorphine treatment, and compare them with their physician counterparts and across varying levels of practice autonomy.
Patients with new-onset low back pain who initially consulted a chiropractor or physical therapist vs a primary care physician were found to have reduced risk for long-term opioid use.
Treatment with lofexidine may provide better control of the symptoms of opioid withdrawal syndrome compared with placebo.
The drugs most frequently involved in drug overdose deaths in 2017 varied regionally in the United States.
